School of Psychiatry and Clinical Neurosciences, University of Western Australia, 35 Stirling Hwy, Crawley, 6009 WA, Australia; Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), 115 Monash Avenue, Nedlands, 6009 WA, Australia.
School of Psychiatry and Clinical Neurosciences, University of Western Australia, 35 Stirling Hwy, Crawley, 6009 WA, Australia; Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, 6027 WA, Australia; Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), 115 Monash Avenue, Nedlands, 6009 WA, Australia.
Neurosci Biobehav Rev. 2016 May;64:215-28. doi: 10.1016/j.neubiorev.2016.01.004. Epub 2016 Feb 17.
Traumatic brain injury (TBI) increases the risk of neurodegenerative disorders many years post-injury. However, molecular mechanisms underlying the relationship between TBI and neurodegenerative diseases, such as Alzheimer's disease (AD), remain to be elucidated. Nevertheless, previous studies have demonstrated a link between TBI and increased amyloid-β (Aβ), a protein involved in AD pathogenesis. Here, we review animal studies that measured Aβ levels following TBI. In addition, from a pool of initially identified 1209 published papers, we examined data from 19 eligible animal model studies using a meta-analytic approach. We found an acute increase in cerebral Aβ levels ranging from 24h to one month following TBI (overall log OR=2.97 ± 0.40, p<0.001). These findings may contribute to further understanding the relationship between TBI and future dementia risk. The methodological inconsistencies of the studies discussed in this review suggest the need for improved and more standardised data collection and study design, in order to properly elucidate the role of TBI in the expression and accumulation of Aβ.
创伤性脑损伤 (TBI) 会增加神经退行性疾病的风险,这种风险在受伤多年后仍然存在。然而,TBI 与神经退行性疾病(如阿尔茨海默病,AD)之间的关系的分子机制仍有待阐明。尽管如此,先前的研究已经表明 TBI 与淀粉样蛋白-β(Aβ)的增加之间存在联系,Aβ 是 AD 发病机制中的一种蛋白。在这里,我们综述了测量 TBI 后 Aβ 水平的动物研究。此外,从最初确定的 1209 篇已发表论文中,我们通过荟萃分析方法检查了 19 项符合条件的动物模型研究的数据。我们发现,TBI 后大脑 Aβ 水平会在 24 小时至一个月内急性增加(总体对数比值=2.97±0.40,p<0.001)。这些发现可能有助于进一步了解 TBI 与未来痴呆风险之间的关系。本综述中讨论的研究在方法学上存在不一致性,这表明需要改进和更标准化的数据收集和研究设计,以正确阐明 TBI 在 Aβ表达和积累中的作用。